Several studies suggest that AhR selectively induces IDO2 expression [37–40], and recent findings from COVID-19 models highlight a potential IDO2-driven positive feedback loop sustaining AhR activation in severe disease [41, 42]. This evidence concerns the gene IDO2 and COVID-19.